Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.59
(0.56%)
CNY 3.59
(0.56%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.62 Billion CNY | -26.98% |
| 2022 | 18.66 Billion CNY | 9.12% |
| 2021 | 17.1 Billion CNY | 42.28% |
| 2020 | 12.01 Billion CNY | 144.2% |
| 2019 | 4.92 Billion CNY | 48.91% |
| 2018 | 3.3 Billion CNY | 30.22% |
| 2017 | 2.53 Billion CNY | 48.28% |
| 2016 | 1.71 Billion CNY | 26.96% |
| 2015 | 1.34 Billion CNY | 45.46% |
| 2014 | 926.86 Million CNY | 30.46% |
| 2013 | 710.44 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 12.4 Billion CNY | -1.53% |
| 2024 Q1 | 12.59 Billion CNY | -7.53% |
| 2024 Q3 | 11.81 Billion CNY | -4.79% |
| 2023 Q4 | 13.62 Billion CNY | -17.63% |
| 2023 Q2 | 17.13 Billion CNY | -7.63% |
| 2023 Q1 | 18.55 Billion CNY | -0.56% |
| 2023 FY | 13.62 Billion CNY | -26.98% |
| 2023 Q3 | 16.54 Billion CNY | -3.49% |
| 2022 Q1 | 17.78 Billion CNY | 3.99% |
| 2022 FY | 18.66 Billion CNY | 9.12% |
| 2022 Q4 | 18.66 Billion CNY | -0.56% |
| 2022 Q2 | 18.33 Billion CNY | 3.08% |
| 2022 Q3 | 18.76 Billion CNY | 2.38% |
| 2021 Q2 | 16.59 Billion CNY | 5.96% |
| 2021 Q3 | 17.22 Billion CNY | 3.79% |
| 2021 Q4 | 17.1 Billion CNY | -0.7% |
| 2021 FY | 17.1 Billion CNY | 42.28% |
| 2021 Q1 | 15.65 Billion CNY | 30.28% |
| 2020 Q2 | 7.97 Billion CNY | 36.54% |
| 2020 Q4 | 12.01 Billion CNY | 13.97% |
| 2020 Q3 | 10.54 Billion CNY | 32.18% |
| 2020 FY | 12.01 Billion CNY | 144.2% |
| 2020 Q1 | 5.84 Billion CNY | 18.73% |
| 2019 Q4 | 4.92 Billion CNY | 8.86% |
| 2019 FY | 4.92 Billion CNY | 48.91% |
| 2019 Q2 | 3.93 Billion CNY | 11.25% |
| 2019 Q3 | 4.52 Billion CNY | 14.88% |
| 2019 Q1 | 3.53 Billion CNY | 7.03% |
| 2018 Q2 | 3.14 Billion CNY | 2.16% |
| 2018 FY | 3.3 Billion CNY | 30.22% |
| 2018 Q4 | 3.3 Billion CNY | -0.85% |
| 2018 Q3 | 3.33 Billion CNY | 5.87% |
| 2018 Q1 | 3.08 Billion CNY | 21.42% |
| 2017 FY | 2.53 Billion CNY | 48.28% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 1.99 Billion CNY | 0.0% |
| 2017 Q3 | 2.39 Billion CNY | 19.91% |
| 2017 Q4 | 2.53 Billion CNY | 5.85% |
| 2016 Q4 | 1.71 Billion CNY | 0.0% |
| 2016 FY | 1.71 Billion CNY | 26.96% |
| 2015 FY | 1.34 Billion CNY | 45.46% |
| 2014 FY | 926.86 Million CNY | 30.46% |
| 2013 FY | 710.44 Million CNY | 0.0% |